Geode Capital Management
LUNG icon

Geode Capital Management’s Pulmonx LUNG Stock Holding History

Geode Capital Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Sell
452,684
-491,808
-52% -$678K ﹤0.01% 3534
2026
Q1 		$1.22M Buy
944,492
+37,971
+4% +$62.7K ﹤0.01% 3300
2025
Q4 		$2M Sell
906,521
-72,241
-7% -$136K ﹤0.01% 3169
2025
Q3 		$1.59M Buy
978,762
+49,365
+5% +$103K ﹤0.01% 3260
2025
Q2 		$2.41M Buy
929,397
+1,856
+0.2% +$7.32K ﹤0.01% 3080
2025
Q1 		$6.24M Buy
927,541
+25,301
+3% +$179K ﹤0.01% 2550
2024
Q4 		$6.13M Buy
902,240
+9,454
+1% +$62.3K ﹤0.01% 2644
2024
Q3 		$7.4M Buy
892,786
+11,151
+1% +$80.7K ﹤0.01% 2543
2024
Q2 		$5.59M Buy
881,635
+47,111
+6% +$362K ﹤0.01% 2663
2024
Q1 		$7.74M Buy
834,524
+28,019
+3% +$329K ﹤0.01% 2476
2023
Q4 		$10.3M Buy
806,505
+42,138
+6% +$439K ﹤0.01% 2330
2023
Q3 		$7.9M Buy
764,367
+27,374
+4% +$317K ﹤0.01% 2402
2023
Q2 		$9.66M Buy
736,993
+36,851
+5% +$451K ﹤0.01% 2305
2023
Q1 		$7.83M Buy
700,142
+40,546
+6% +$400K ﹤0.01% 2405
2022
Q4 		$5.56M Buy
659,596
+30,222
+5% +$287K ﹤0.01% 2611
2022
Q3 		$10.5M Buy
629,374
+23,042
+4% +$424K ﹤0.01% 2214
2022
Q2 		$8.93M Buy
606,332
+67,340
+12% +$1.39M ﹤0.01% 2342
2022
Q1 		$13.4M Sell
538,992
-700
-0.1% -$18.1K ﹤0.01% 2151
2021
Q4 		$17.3M Buy
539,692
+21,153
+4% +$773K ﹤0.01% 2055
2021
Q3 		$18.7M Buy
518,539
+203,361
+65% +$8M ﹤0.01% 2007
2021
Q2 		$13.9M Buy
315,178
+109,152
+53% +$4.75M ﹤0.01% 2230
2021
Q1 		$9.42M Buy
206,026
+6,623
+3% +$380K ﹤0.01% 2401
2020
Q4 		$13.8M Buy
+199,403
New +$9.77M ﹤0.01% 1944

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management's LUNG Position: Q2 2026 in Review

Geode Capital Management reduced its Pulmonx (LUNG) stake by 52% in Q2 2026, selling an estimated $678K and leaving 452,684 shares worth $589K. The position accounts for ﹤0.01% of the portfolio, ranked #3534.

Geode Capital Management first reported a position in LUNG in Q4 2020 and has held it in 23 quarters since. The position peaked at $18.7M in Q3 2021. 98 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Geode Capital Management held 452,684 shares of Pulmonx worth $589K as of Q2 2026.
  • Geode Capital Management sold 491,808 Pulmonx shares in Q2 2026, an estimated $678K.
  • Pulmonx made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3534 holding.
  • Geode Capital Management first reported a position in Pulmonx in Q4 2020 and has held it in 23 quarters since.
  • Geode Capital Management's Pulmonx position peaked at $18.7M in Q3 2021.
  • 98 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.